Saarvienin A—A Novel Glycopeptide with Potent Activity against Drug‐Resistant Bacteria

A member of a new family of glycopeptides, named saarvienin A, was isolated from a rare actinomycete Amycolatopsis sp. YIM10. Extensive NMR and MS analyses revealed a halogenated peptide core comprising four amino acids cyclized via a ureido linkage with an exocyclic 2-hydroxy-3-(4-hydroxyphenyl)propyl residue connected to a five-sugar/aminosugar chain. Two of the three aminosugars constitute the N-methylated and N,O-dimethylated derivatives of eremosamine (4-epi-vancosamine) that have not been reported in any natural product. Saarvienin A exhibits potent activity against a range of Gram-positive bacteria, effectively overcoming resistance to several frontline antibiotics in clinical isolates. It demonstrates an eight-fold reduction in minimum inhibitory concentrations (MICs) against methicillin-resistant, vancomycin-intermediate, and daptomycin-resistant Staphylococcus aureus compared to vancomycin.

Authors

Institutions

Publication Details

Journal
Angewandte Chemie International Edition
Published
2025-04-18
DOI
https://doi.org/10.1002/anie.202425588
Citations
3
Primary Topic
Microbial Natural Products and Biosynthesis
Type
article
Field-Weighted Citation Impact
4.18

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Saarvienin A—A Novel Glycopeptide with Potent Activity against Drug‐Resistant Bacteria

Bernd Morgenstern, Sari Rasheed, Franziska Fries, Sergey B. Zotchev et al.
3 citations
Angewandte Chemie International Edition
Microbial Natural Products and Biosynthesis
4.18
article

Saarvienin A—A Novel Glycopeptide with Potent Activity against Drug‐Resistant Bacteria

Bernd Morgenstern, Sari Rasheed, Franziska Fries, Sergey B. Zotchev, Jaime Felipe Guerrero Garzón, Martin Zehl, Rolf Müller, Amninder Kaur
article en
3 citations

Abstract

A member of a new family of glycopeptides, named saarvienin A, was isolated from a rare actinomycete Amycolatopsis sp. YIM10. Extensive NMR and MS analyses revealed a halogenated peptide core comprising four amino acids cyclized via a ureido linkage with an exocyclic 2-hydroxy-3-(4-hydroxyphenyl)propyl residue connected to a five-sugar/aminosugar chain. Two of the three aminosugars constitute the N-methylated and N,O-dimethylated derivatives of eremosamine (4-epi-vancosamine) that have not been reported in any natural product. Saarvienin A exhibits potent activity against a range of Gram-positive bacteria, effectively overcoming resistance to several frontline antibiotics in clinical isolates. It demonstrates an eight-fold reduction in minimum inhibitory concentrations (MICs) against methicillin-resistant, vancomycin-intermediate, and daptomycin-resistant Staphylococcus aureus compared to vancomycin.

Angewandte Chemie International EditionVol. 64(25)
University of Vienna (AT), German Center for Infection Research (DE), Helmholtz Centre for Infection Research (DE), Helmholtz Institute for Pharmaceutical Research Saarland (DE), Saarland University (DE)
Deutsches Zentrum für Infektionsforschung, Universität Wien, Universität des Saarlandes, Universität Zürich, Institut für Medizinische Mikrobiologie, Universität Zürich
Openalex Percentile: Top 7%
Microbial Natural Products and Biosynthesis
4.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.